These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up. Laftavi MR; Alnimri M; Weber-Shrikant E; Kohli R; Said M; Patel S; Pankewycz O Transplant Proc; 2011 Mar; 43(2):458-61. PubMed ID: 21440733 [TBL] [Abstract][Full Text] [Related]
11. Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial. Eason JD; Loss GE; Blazek J; Nair S; Mason AL Liver Transpl; 2001 Aug; 7(8):693-7. PubMed ID: 11510013 [TBL] [Abstract][Full Text] [Related]
12. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance. Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971 [TBL] [Abstract][Full Text] [Related]
13. Induction of immunosuppression with rabbit antithymocyte globulin: five-year experience in cardiac transplantation. Carrier M; Pelletier GB; Cartier R; Leclerc Y; Robitaille D; Pelletier LC Can J Cardiol; 1993 Mar; 9(2):171-6. PubMed ID: 8490788 [TBL] [Abstract][Full Text] [Related]
14. Renal transplantation in the setting of early steroid withdrawal: a comparison of rabbit antithymocyte globulin induction dosing in two eras. Rogers CC; Asipenko N; Horwedel T; Gautam S; Goldfarb-Rumyantzev AS; Pavlakis M; Johnson SR; Karp SJ; Evenson A; Khwaja K; Hanto DW; Mandelbrot DA Am J Nephrol; 2013; 38(5):397-404. PubMed ID: 24192457 [TBL] [Abstract][Full Text] [Related]
15. Superior Patient and Graft Survival in Adult Liver Transplant with Rabbit Antithymocyte Globulin Induction: Experience with 595 Patients. Montenovo MI; Jalikis FG; Li M; Yeh M; Dick A; Hansen R; Reyes JD Exp Clin Transplant; 2017 Aug; 15(4):425-431. PubMed ID: 27309029 [TBL] [Abstract][Full Text] [Related]
16. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation. Farney AC; Doares W; Rogers J; Singh R; Hartmann E; Hart L; Ashcraft E; Reeves-Daniels A; Gautreaux M; Iskandar SS; Moore P; Adams PL; Stratta RJ Transplantation; 2009 Sep; 88(6):810-9. PubMed ID: 19920781 [TBL] [Abstract][Full Text] [Related]
18. Antithymocyte Globulin Induction Therapy in Liver Transplant: Old Drug, New Uses. Petite SE; Bollinger JE; Eghtesad B Ann Pharmacother; 2016 Jul; 50(7):592-8. PubMed ID: 27147705 [TBL] [Abstract][Full Text] [Related]
19. Growth pre- and postimplementation of a steroid-free induction protocol in a large pediatric intestinal transplant population. Nucci AM; Strohm S; Squires RH; Mazariegos GV; Sun Q; Sindhi R J Pediatr Gastroenterol Nutr; 2011 May; 52(5):601-6. PubMed ID: 21464750 [TBL] [Abstract][Full Text] [Related]
20. Outcomes of Early Steroid Withdrawal in Recipients of Deceased-Donor Expanded Criteria Kidney Transplants in the Era of Induction Therapy. Hussain SM; Marcus RJ; Ko TY; Nashar K; Thai NL; Sureshkumar KK Exp Clin Transplant; 2016 Jun; 14(3):287-93. PubMed ID: 27221720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]